Excess Body Mass Index and Risk of Liver Cancer: A Nonlinear Dose-Response Meta-Analysis of Prospective Studies

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Rui, Rui ^a   Lou, Jiao ^a   Zou, Li ^a   Zhong, Rong ^a   Wang, Ji ^b   Xia, Ding ^a   Wang, Qi ^a   Li, Heng ^a   Wu, Jing ^a   Lu, Xuzai ^a   Li, Chuanqi ^a   Liu, Li ^c   Xia, Jiahong ^d   Xu, Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; ETHNICITY; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; REGRESSION ANALYSIS; SELF REPORT; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

BODY MASS INDEX; HUMANS; LIVER NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84866480533     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044522     Document Type: Article

References (51)

1. Bosch FX, Ribes J, Diaz M, Cleries R, (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16.
2. Llovet JM, Burroughs A, Bruix J, (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917.
3. McGlynn KA, London WT, (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19: 3-23.
4. Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, et al. (2009) The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 20: 353-357.
5. Chuang SC, La Vecchia C, Boffetta P, (2009) Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 286: 9-14.
6. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H, (2009) Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 15: 280-288.
7. Farrell GC, Larter CZ, (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43: S99-S112.
8. Gao C, Yao SK, (2009) Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int 8: 465-473.
9. Parr CL, Batty GD, Lam TH, Barzi F, Fang X, et al. (2010) Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. Lancet Oncol 11: 741-752.
10. Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, et al. (2005) Obesity and risk of cancer in Japan. Int J Cancer 113: 148-157.
11. Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, et al. (2005) Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93: 1062-1067.
12. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ, (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638.
13. Larsson SC, Wolk A, (2007) Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 97: 1005-1008.
14. Chen Y, Wang X, Wang J, Yan Z, Luo J, (2012) Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies. Eur J Cancer.
15. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M, (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371: 569-578.
16. Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, et al. (2012) Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 23: 843-852.
17. Larsson SC, Orsini N, (2011) Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol 174: 993-1001.
18. Harrell FE Jr, Lee KL, Pollock BG, (1988) Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 80: 1198-1202.
19. Orsini N, Bellocco R, Greenland S, (2006) Generalized least squares for trend estimation of summarized dose-response data. The stata journal 6: 40-57.
20. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
21. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
22. Orsini N, Greenland S, (2011) A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. The stata journal 11: 1-29.
23. Tobias A, (1999) Assessing the influence of a single study in meta-analysis. Stata Technical Bulletin 8: 15-17.
24. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
25. Oh SW, Yoon YS, Shin SA, (2005) Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 23: 4742-4754.
26. Jee SH, Yun JE, Park EJ, Cho ER, Park IS, et al. (2008) Body mass index and cancer risk in Korean men and women. Int J Cancer 123: 1892-1896.
27. Batty GD, Shipley MJ, Jarrett RJ, Breeze E, Marmot MG, et al. (2005) Obesity and overweight in relation to organ-specific cancer mortality in London (UK): findings from the original Whitehall study. Int J Obes (Lond) 29: 1267-1274.
28. Nair S, Mason A, Eason J, Loss G, Perrillo RP, (2002) Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 36: 150-155.
29. Joshi S, Song YM, Kim TH, Cho SI, (2008) Socio-economic status and the risk of liver cancer mortality: a prospective study in Korean men. Public Health 122: 1144-1151.
30. Hart CL, Batty GD, Morrison DS, Mitchell RJ, Smith GD, (2010) Obesity, overweight and liver disease in the Midspan prospective cohort studies. Int J Obes (Lond) 34: 1051-1059.
31. Moller H, Mellemgaard A, Lindvig K, Olsen JH, (1994) Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A: 344-350.
32. Wolk A, Gridley G, Svensson M, Nyren O, McLaughlin JK, et al. (2001) A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 12: 13-21.
33. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, et al. (2004) Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15: 35-43.
34. Wang CS, Yao WJ, Chang TT, Wang ST, Chou P, (2009) The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 18: 2054-2060.
35. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, et al. (2008) Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135: 111-121.
36. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, et al. (2007) Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 5: 938-945, 945 e931-934.
37. N'Kontchou G, Paries J, Htar MT, Ganne-Carrie N, Costentin L, et al. (2006) Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol 4: 1062-1068.
38. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr, (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17: 901-909.
39. Yu MW, Shih WL, Lin CL, Liu CJ, Jian JW, et al. (2008) Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol 26: 5576-5582.
40. Kelly T, Yang W, Chen CS, Reynolds K, He J, (2008) Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 32: 1431-1437.
41. Deurenberg P, Deurenberg-Yap M, Guricci S, (2002) Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 3: 141-146.
42. Yeh SH, Chen PJ, (2010) Gender disparity of hepatocellular carcinoma: the roles of sex hormones. Oncology 78 Suppl 1: 172-179.
43. Ding EL, Song Y, Malik VS, Liu S, (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295: 1288-1299.
44. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, et al. (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98: 920-931.
45. Aune D, Greenwood DC, Chan DS, Vieira R, Vieira AR, et al. (2011) Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol.
46. Wiseman M, (2008) The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 67: 253-256.
47. Toffanin S, Friedman SL, Llovet JM, (2010) Obesity, inflammatory signaling, and hepatocellular carcinoma-an enlarging link. Cancer Cell 17: 115-117.
48. Jenks S, (2010) Researchers explore mechanisms that may link obesity and cancer. J Natl Cancer Inst 102: 519-521.
49. Takamatsu S, Noguchi N, Kudoh A, Nakamura N, Kawamura T, et al. (2008) Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma. Hepatogastroenterology 55: 609-614.
50. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM, (2001) Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61: 5016-5023.
51. Giovannucci E, (2003) Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 35: 694-704.